MarketPeel
Insider Trading Intelligence
WK

Winston Kung

PMVP
COO, CFO · PMV PHARMACEUTICALS, INC. · CIK 0001666963
FILING MIX · LIFETIME66%/34%
BUYS
27
SELLS
14
TOTAL VALUE
$715.9K
COMPANIES
4
ACTIVE SINCE
Dec 2020
HOLDINGS NOW
317,640
AVG SELL PX
$31.15
TRADE KIND
SHOWING 41 / 41
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by Winston Kung, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+0.00%+2.06%+0.40%+1.66%+1.88%
14d4+25.00%+1.36%-0.11%+1.47%+1.73%
30d4+75.00%-1.52%+2.22%-3.74%-4.70%
60d4+75.00%-5.51%+3.08%-8.58%-8.37%
90d4+75.00%-12.51%+4.61%-17.12%-16.08%
180d4+100.00%-37.87%+8.02%-45.88%-44.15%
1y4+100.00%-54.93%-3.48%-51.45%-53.67%
2y4+100.00%-81.62%+3.61%-85.23%-86.04%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
PMVP · 150,000 shares · as of May 12, 2023
059,259118,517177,776237,034202120222023SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 27 buys / 14 sellsCOVERAGE · 23 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
JANX
JANUX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
15,50015,500Jun 11, 2026Jun 12, 2026View →
JANX
JANUX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,50011,750Jun 11, 2026Jun 12, 2026View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
SALE10b5-1
10b5-1 plan
2,026$7.91$16.0K12,140Jun 10, 2026Jun 11, 2026View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
12,30012,300May 19, 2026May 21, 2026View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
3,80014,166May 19, 2026May 21, 2026View →
AVBP
ARRIVENT BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
140,000140,000Feb 2, 2026Feb 4, 2026View →
JANX
JANUX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
3,7506,250Jun 11, 2025Jun 13, 2025View →
JANX
JANUX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
11,66711,667Jun 11, 2025Jun 13, 2025View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
4,80010,366May 30, 2025Jun 2, 2025View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
16,00016,000May 30, 2025Jun 2, 2025View →
AVBP
ARRIVENT BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
120,000120,000Feb 3, 2025Feb 14, 2025View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
5,5665,566Aug 16, 2024Aug 20, 2024View →
CRBP
CORBUS PHARMACEUTICALS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
5,5665,566Aug 16, 2024Aug 20, 2024View →
JANX
JANUX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
8,3508,350Jun 26, 2024Jun 27, 2024View →
JANX
JANUX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
2,5002,500Jun 26, 2024Jun 27, 2024View →
JANX
JANUX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
12,50012,500Jun 14, 2023Jun 16, 2023View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
150,000150,000May 12, 2023May 15, 2023View →
PMVP
PMV PHARMACEUTICALS, INC.
SALEGRANT
Gift
2,56010,600Nov 25, 2022Jan 30, 2022View →
JANX
JANUX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
9,3759,375Sep 21, 2022Sep 22, 2022View →
JANX
JANUX THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
30,00030,000Sep 21, 2022Sep 22, 2022View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
COO, CFO
4,000$3.22$12.9K10,600Apr 20, 2022Apr 21, 2022View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
COO, CFO
4,000210,034Apr 20, 2022Apr 21, 2022View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
104,400104,400Feb 10, 2022Feb 28, 2022View →
PMVP
PMV PHARMACEUTICALS, INC.
SALEGRANT
Gift
2,7256,600Dec 30, 2021Feb 8, 2022View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
COO, CFO
5,000214,034Aug 19, 2021Aug 20, 2021View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
COO, CFO
5,000$3.22$16.1K6,600Aug 19, 2021Aug 20, 2021View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
COO, CFO
4,500$33.82$152.2K1,600Aug 3, 2021Aug 4, 2021View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
COO, CFO
4,500$3.22$14.5K6,100Aug 3, 2021Aug 4, 2021View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
COO, CFO
4,500219,034Aug 3, 2021Aug 4, 2021View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
COO, CFO
4,500$3.22$14.5K6,100Jul 8, 2021Jul 8, 2021View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
COO, CFO
4,500223,534Jul 8, 2021Jul 8, 2021View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
COO, CFO
4,500$33.75$151.9K1,600Jul 8, 2021Jul 8, 2021View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
COO, CFO
4,500228,034Jun 4, 2021Jun 7, 2021View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
COO, CFO
4,500$33.75$151.9K1,600Jun 4, 2021Jun 7, 2021View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
COO, CFO
4,500$3.22$14.5K6,100Jun 4, 2021Jun 7, 2021View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
50,33750,337May 12, 2021Jun 8, 2021View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
COO, CFO
4,500$3.22$14.5K6,100May 3, 2021May 4, 2021View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
COO, CFO
4,500$33.75$151.9K1,600May 3, 2021May 4, 2021View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
COO, CFO
4,500232,534May 3, 2021May 4, 2021View →
PMVP
PMV PHARMACEUTICALS, INC.
PURCHASE
COO, CFO
1,600$3.22$5.2K1,600Dec 8, 2020Dec 31, 2020View →
PMVP
PMV PHARMACEUTICALS, INC.
SALE
COO, CFO
1,600237,034Dec 8, 2020Dec 31, 2020View →
Other insiders · PMVP
Loading peer insiders…
About this filer
CIK 0001666963
ROLE
COO, CFO
PRIMARY
PMVP
COMPANIES
4
ACTIVE SINCE
Dec 2020
MARKETPEEL · /INSIDER/0001666963DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback